Ardelyx, Inc. (ARDX)
6.04
-0.70
(-10.39%)
USD |
NASDAQ |
Feb 20, 10:42
Ardelyx Shareholders Equity (Quarterly) : 154.28M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 617.97M |
| MannKind Corp. | -44.55M |
| Vertex Pharmaceuticals, Inc. | 18.67B |
| Fate Therapeutics, Inc. | 234.07M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 486.17M |
| Total Liabilities (Quarterly) | 331.89M |
| Debt to Equity Ratio | 1.346 |
| Current Ratio | 4.413 |
| Net Debt Paydown Yield | -1.53% |